New Delhi. The whole world is eagerly awaiting the corona vaccine. Pfizer Inc., meanwhile, says the Korana vaccine has been found to be 95 percent effective in a final analysis of a third-phase trial. At the same time, the way is clear for the company to apply to US regulators for final approval in the next few days.
Pfizer says Covid-19 vaccine trial complete, cites shot is 95 per cent effective
– ANI Digital (ani_digital) November 18, 2020
The American pharmaceutical company and its partner Bioentech SE says their vaccine has saved people of all ages and classes from corona and has not yet caused any serious safety problems.
About 44 thousand people have been vaccinated in the trial. Shares of Pfizer jumped 2.7 percent in pre-market trading after the announcement on behalf of the pharmaceutical company. Shares of Bioentech also rose 7.3 per cent.
In the last few days, there have been many hopeful reports about the corona virus. Moderna Inc. also claims a 94.5 percent effective vaccine. With this, Russian Sputnik V has also described his vaccine as 92 per cent effective. In the coming days, trial data from AstraZeneca PLC and Oxford University will also be put forward.